Stomach Cancer

FDA Approves Cyramza (ramucirumab) for Stomach Cancer

The US Food and Drug Administration (FDA) has approved Cyramza (ramucirumab) to treat advanced stomach cancer and gastroesophageal junction adenocarcinoma, a type of cancer located where the stomach connects to the esophagus.

Study: Hodgkin Disease Treatment May Raise Stomach Cancer Risk

Researchers from the National Cancer Institute (NCI) have found that certain radiation and chemotherapy treatment regimens for Hodgkin disease may increase the risk of stomach cancer.